Leapfrog Remedies Ltd

Leapfrog Remedies Ltd is a small, active company based in London, UK, founded five years ago. It’s a solo founder operation with one director and one employee, holding assets of £314,670. The company operates an e-commerce site and is an irregular importer, primarily dealing in natural and modified starches, glues, and enzymes, with its last import activity occurring one month ago. It’s also worth noting that the company operates in the manufacture of other food products.

The company’s website, Leapfrog Remedies, focuses on immune support, sleep enhancement, and mental clarity through supplements like Lactoferrin. It positions itself as a UK leader in Lactoferrin-based products, highlighting science-backed benefits and positive customer reviews. The site’s design emphasizes wellness and targets consumers seeking natural solutions for immunity, sleep, and stress management. It's a well-presented site, with a clear focus on its key products and a blog section offering wellness tips.

Financially, Leapfrog Remedies Ltd shows a mixed picture. Cash reserves have increased significantly, jumping 80% to £220,000—a positive sign. However, net assets also increased by 92% to £220,000. Trade debtors have increased by 220%, which could indicate an increase in sales but also a potential challenge in collecting payments. Creditors have also increased by 34%, which is normal as the company grows. The company meets the criteria to be considered a small company, with turnover under £10.2m, assets under £5.1m, and fewer than 50 employees. There is no auditor mentioned, so the figures are unaudited.

Overall, Leapfrog Remedies Ltd seems to be growing, but it’s important to monitor its ability to manage its increasing trade debtors. The company’s focus on a niche market and its well-designed e-commerce site suggest a potential for continued success.

Registered in England/Wales under the registration number 12336542, with a registered address at SW11 5GY, England, London, 16 Southside Quarter 38 Burns Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.